Epigenomics Revenue and Competitors
Estimated Revenue & Valuation
- Epigenomics's estimated annual revenue is currently $10.8M per year.
- Epigenomics's estimated revenue per employee is $155,000
Employee Data
- Epigenomics has 70 Employees.
- Epigenomics grew their employee count by 4% last year.
Epigenomics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CFO / Vorstand | Reveal Email/Phone |
2 | VP Clinical and Scientifc Affairs | Reveal Email/Phone |
3 | EVP Finance | Reveal Email/Phone |
4 | Director, Technical Support & CRA | Reveal Email/Phone |
5 | President & Chief Scientific Officer | Reveal Email/Phone |
6 | Area Business Manager | Reveal Email/Phone |
7 | Executive Administrative Assistant & HR Manager | Reveal Email/Phone |
8 | Manager Clinical Affairs | Reveal Email/Phone |
9 | Research Associate and Facilities Management | Reveal Email/Phone |
10 | National Speaker | Reveal Email/Phone |
Epigenomics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Epigenomics?
Epigenomics is a molecular diagnostics company focused on the development of blood-based DNA methylation tests for the early the detection of cancer. The Epi proColon test has recently become the first and only FDA approved blood test for colorectal cancer screening. Epi proColon, HCCBloodTest, and the Epi proLung tests are available in Europe as CE-marked IVDs. Industry partners, as well as the medical and life science communities, can access our expansive intellectual property portfolio. Epigenomics has been granted over 60 patents, in addition to many others that have been filed. These patents cover DNA methylation technologies and biomarkers, as well as our DNA methylation expertise through research products, biomarker services, IVD development collaborations, and licensing.
keywords:N/A
N/A
Total Funding
70
Number of Employees
$10.8M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Epigenomics News
Beckman Coulter; Alere; Epigenomics; Eiken Chemical; Sysmex; Siemens Healthcare; Quest Diagnostics; Companion Dx; Oncocyte; Merck Millipore...
... Upcoming Trends, Future Demands and Forecast by 2030 | Astellas Pharma Inc., Myriad Genetics, Epigenomics, Radient Pharmaceuticals.
NEW YORK Epigenomics on Thursday posted a sharp year-over-year increase in revenues for 2021, even as sales of its diagnostic test kits fell,...
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5.4M | 70 | -21% | $47M |
#2 | $8.8M | 70 | -10% | N/A |
#3 | $9.1M | 70 | -7% | N/A |
#4 | $17M | 70 | -31% | N/A |
#5 | $8.8M | 70 | 0% | $24.5M |